Diagnosis and Management of ALS During COVID-19
A panel of key opinion leaders provides insight into how COVID-19 has continued to impact the diagnosis and management of patients with amyotrophic lateral sclerosis (ALS).
Counseling Patients On High-Efficacy Therapy for RRMS
May 3rd 2021Robert Fox, MD, of the Cleveland Clinic, comments on the advantage of starting treatment with a high-efficacy therapy for relapsing-remitting multiple sclerosis and explains his approach to counseling patients when selecting treatment.
Treating RRMS: Low Vs High-Efficacy Therapy
May 3rd 2021Dr Patricia K. Coyle, of the Stony Brook Neurosciences Institute, comments on her approach to selecting first-line therapy to treat relapsing-remitting multiple sclerosis, explaining how she selects between a lower-risk or high-efficacy therapy.
AUPN Leadership Minute Episode 10: What Your CEO Wants From You
May 1st 2021Episode 10 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University and Robert C. Byrd Health; and Albert L. Wright, Jr., the president and CEO of West Virginia University Health System. [WATCH TIME: 4 minutes]
Evaluating Solriamfetol in Patients Adherent to OSA Therapy: Paula K. Schweitzer, PhD
April 30th 2021The director of research at St. Luke’s Sleep Medicine and Research Center discussed the motivation behind her study assessing solriamfetol in patient’s adherent and nonadherent to primary OSA therapy.
The Role of Primary Care Physicians in Diagnosing SMA
Key opinion leaders in neurology comment on the importance of awareness and urgency in the primary care setting to diagnose spinal muscular atrophy and refer the patient to a specialist.
Impact of Genetic Testing on Treatment Considerations
A panel of experts in SMA builds a lively discussion on the accuracy and prognostic value of genetic testing and screening and examines how results may impact treatment considerations.
MS: Nutrition and Managing Cognitive Impairment
The importance of proper nutrition as a therapy for symptom control in multiple sclerosis and some strategies to manage cognitive impairment.
Shared Decision-Making and Complementary Therapies in Progressive MS
Joseph R. Berger, MD, elaborates on the importance of shared decision making in the treatment of multiple sclerosis and how it relates to complementary and natural therapies for symptom control.
Treating Migraine in the Community Setting
April 28th 2021Advice to community neurologists and other care providers who may treat patients with migraine in the community setting on incorporating newer therapies, such as CGRP inhibitors, into practice, and a list of reputable resources where patients can turn for additional support.